 Integra LifeSciences Holdings Corporation NASDAQ: IART shares got a boost as Q3 adjusted EPS of 0.86 topped the consensus forecast of 0.72. Revenues increased 4.5 YY 6.7 organically to 386.9 million, beating the consensus of 384.58 million, due to higher sales from instruments and Wound Reconstruction Care. 